MolNFT v1 · #401916 · protein
AlphaFold monomer V2.0 prediction for 30S ribosomal protein S1 (A0QYY6)
A0QYY6: “AlphaFold monomer V2.0 prediction for 30S ribosomal protein S1 (A0QYY6)”. 3 pockets (best druggability 0.59). MolNFT v1 #401916 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- A0QYY6
- Type
- protein
- Length
- 479 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x5BeA89782341f98147F2D811B063F91F0aE7D7bF
- Molecule
- 30S ribosomal protein S1
- UniProt
- A0QYY6
- Pockets
- 3 · best druggability 0.59
Structure
1 distinct chain · 30% helix, 30% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 30S ribosomal protein S1 | protein | 479 | 30% helix, 30% strand | A0QYY6 |
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 363 | 0.59 | 0.76 | 33 | empty |
| 2 | 71 | 0.34 | 0.75 | 16 | empty |
| 3 | 62 | 0.27 | 0.73 | 13 | empty |
Compared structures
- 8WI7 · Cryo- EM structure of Mycobacterium smegmatis 70S ribosome, bS1 and RafH. · an experimental structure of the same protein · chain A against b, TM-score 0.29
- 4NNH · Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by… · an experimental structure of the same protein · chain A against A, TM-score 0.28
- 4NNH · Structural basis for targeting the ribosomal protein S1 of mycobacterium tuberculosis by… · an experimental structure of the same protein · chain A against A, TM-score 0.28
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0QYY6
- Elsewhere: UniProt A0QYY6 · AlphaFold DB A0QYY6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.